SOLV
Solventum Corp
NYSE · Healthcare · Medical - Care Facilities · US
$83.56
+2.09%Year over year
Reported trailing growth
- Revenue
- -0.9%
- EBITDA
- +93.4%
- EBIT
- +167.3%
- EPS
- +275.3%
- Free cash flow
- —
- Operating cash flow
- -64.3%
Forward estimates
Based on analyst estimates
- Revenue
- +1.7%
- EBITDA
- -7.9%
- EPS
- -12.4%
Three-year CAGR
- Revenue
- +0.8%
- EBITDA
- +3.9%
- EBIT
- +8.8%
- Net income
- +5.0%
- EPS
- +4.7%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026